Cargando…
Treatment of Chagas Disease in the United States
PURPOSE OF REVIEW: Chagas disease (CD) is endemic to much of Latin America, but also present in the United States (U.S.). Following a lengthy asymptomatic period, CD produces serious cardiac or gastrointestinal complications in 30–40% of people. Less than 1% of the estimated six million cases in the...
Autores principales: | Meymandi, Sheba, Hernandez, Salvador, Park, Sandy, Sanchez, Daniel R., Forsyth, Colin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132494/ https://www.ncbi.nlm.nih.gov/pubmed/30220883 http://dx.doi.org/10.1007/s40506-018-0170-z |
Ejemplares similares
-
The Challenges of Chagas Disease— Grim Outlook or Glimmer of Hope?
por: Tarleton, Rick L, et al.
Publicado: (2007) -
Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States
por: Forsyth, Colin J., et al.
Publicado: (2016) -
A systematic review of historical and current trends in Chagas disease
por: Álvarez-Hernández, Diego-Abelardo, et al.
Publicado: (2021) -
Progression of Baseline Electrocardiogram Abnormalities in Chagas Patients Undergoing Antitrypanosomal Treatment
por: Soverow, Jonathan, et al.
Publicado: (2019) -
Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States
por: Forsyth, Colin, et al.
Publicado: (2019)